'Thrift shop' drugs
By Lenore Skenazy
Published: Monday, Nov. 12, 2012, 8:51 p.m.
Think of it as Goodwill versus Bloomingdale's — except with medicine.
Today most researchers trying to cure a disease are like designers. They start from scratch in a lab, trying to create something unique and miraculous (and, some hope, lucrative).
The odds against them are terrible — for every 10,000 new drugs tested, one actually gets to patients — and the expense is enormous, too; $250 billion in research a year yields maybe 30 new drugs.
Isn't there an alternative?
Call them thrift shop drugs — drugs that were created for some other people with some other disease but that just might work on another ailment, too.
“Think of Benadryl,” says Dr. Bruce Bloom, president and chief science officer of Cures Within Reach, a Chicago philanthropic organization that funds research into “repurposing” old, often inexpensive, medicines.
Benadryl dries up mucous membranes, so it's great for allergies. But it also zonks out anyone (including me) who can't sleep. It's two drugs in one.
Now think of all the other drugs out there for everything from cancer to cataracts. Plenty of those drugs could do more than one thing, too, if scientists bothered to study them. That's the kind of research Cures Within Reach supports.
After all, the “old” drugs have already been given the green light for human use, so that's about a decade of clinical trials they can skip. That's also billions of basic research bucks saved, making them the cheapest way to start treating almost any neglected disease.
Is it the very best treatment? Not always — but that's OK.
“I would say that so far, about a third of the time, the stuff we have is perfect,” Bloom says.
In other words, the repurposed drug does exactly the job a dream drug would do. But even the other two-thirds of the time — when it is not perfect — it is still far better than anything that has been available to date, which is often nothing.
And it's affordable. And it can be used immediately.
If ever there was a case of not letting the perfect be the enemy of the good, here it is — in a pillbox.
How many times does a doctor notice a beneficial side effect of a drug and start offering it, off label, to patients suffering from something else?
It happens all the time.
Now imagine harnessing all those off-label ideas, testing them as quickly as possible and getting them out to people in pain.
Maybe the repurposed drug is perfect; maybe it's not.
But going back to the thrift shop analogy: If you're freezing and you've got the choice between a designer coat that might take years to complete (if ever) and a secondhand jacket that you could throw on today, it's time to come in out of the cold.
That goes for research on repurposing drugs, too.
Lenore Skenazy is the author of “Free-Range Kids: How to Raise Safe, Self-Reliant Children (Without Going Nuts with Worry).”
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Steelers to release LaMarr Woodley; Taylor apparently staying
- Analysis: Steelers could fill needs with free agents while not spending big bucks
- Top pitching prospect Taillon’s time with Pirates must wait
- MLB notebook: Bonds back in Giants camp as coach
- Kovacevic: Big Ben’s contract clock ticking
- Depth, distance reduce impact of quake off California’s northern coast
- Penguins notebook: Heralded Russian Evgeny Kuznetsov debuts with Capitals
- College basketball notebook: Kane (Big 12), McConnell (Pac-12) pick up postseason basketball honors
- Primanti’s manager admits stealing $30,000 from restaurants
- Fannie, Freddie profits surprise
- PNC Broadway Across America — Pittsburgh series is full of favorites